OpenLB
Open Library of Bioscience
Advanced Search
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
11 19, 2020;71 (16): 2246-2248.

Testing for SARS-CoV-2: Can We Stop at 2?

Tau Hong Lee, Ray Junhao Lin, Raymond T P Lin, Timothy Barkham, Pooja Rao, Yee-Sin Leo, David Chien Lye, Barnaby Young, National Centre for Infectious Diseases COVID-19 Outbreak Research Team
Author Information
  1. Tau Hong Lee: National Centre for Infectious Diseases, Singapore.
  2. Ray Junhao Lin: National Centre for Infectious Diseases, Singapore.
  3. Raymond T P Lin: National Centre for Infectious Diseases, Singapore.
  4. Timothy Barkham: Tan Tock Seng Hospital, Singapore.
  5. Pooja Rao: Tan Tock Seng Hospital, Singapore.
  6. Yee-Sin Leo: National Centre for Infectious Diseases, Singapore.
  7. David Chien Lye: National Centre for Infectious Diseases, Singapore.
  8. Barnaby Young: National Centre for Infectious Diseases, Singapore.
PMID: 32306042 DOI: 10.1093/cid/ciaa459

Abstract

The COVID-19 epidemic requires accurate identification and isolation of confirmed cases for effective control. This report describes the effectiveness of our testing strategy and highlights the importance of repeat testing in suspected cases in our cohort.

Keywords

COVID-19 SARS-CoV-2 diagnosis polymerase chain reaction testing

MeSH Term

Adult
COVID-19
COVID-19 Nucleic Acid Testing
Female
Humans
Male
Nasopharynx
Radiography
SARS-CoV-2
Sampling Studies
Thorax
Time Factors
Case Reports Journal Article
Article has an altmetric score of 31

Word Cloud

Created with Highcharts 10.0.0testingcasesCOVID-19epidemicrequiresaccurateidentificationisolationconfirmedeffectivecontrolreportdescribeseffectivenessstrategyhighlightsimportancerepeatsuspectedcohortTestingSARS-CoV-2:CanStop2?COVID-19SARS-CoV-2diagnosispolymerasechainreaction

Similar Articles

Cited By